Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
McKesson
Argus Health
Medtronic
US Army
Johnson and Johnson
Boehringer Ingelheim
Federal Trade Commission

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,732,488

« Back to Dashboard

Summary for Patent: 7,732,488
Title:Pharmaceutical composition comprising low concentrations of environmental pollutants
Abstract:The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above.
Inventor(s): Breivik; Harald (Porsgrunn, NO), Thorstad; Olav (Porsgrunn, NO)
Assignee: Pronova Biopharma Norge AS (Baerum, NO)
Application Number:10/517,812
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,732,488
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 7,732,488

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,732,488

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden0202188Jul 11, 2002
PCT Information
PCT FiledJuly 08, 2003PCT Application Number:PCT/IB03/02827
PCT Publication Date:January 22, 2004PCT Publication Number: WO2004/007654

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
McKinsey
US Department of Justice
Fish and Richardson
AstraZeneca
McKesson
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.